+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt



Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt



Egyptian Journal of Immunology 17(1): 73-86



Hepatitis E virus (HEV) infection is a common cause of acute viral hepatitis (AVH) in Egypt. We aimed to identify risk factors of HEV among acute hepatitis cases, measure HEV specific immune response to differentiate between symptomatic and asymptomatic infections. The study included symptomatic acute hepatitis (AH) patients (n = 235) and asymptomatic contacts (n = 200) to HEV cases. They completed a lifestyle questionnaire, screened for common hepatotropic viruses. Blood and serum samples were collected from patients and contacts after onset of disease and follow-up samples collected until convalescence. PBMC were separated and tested for specific HEV T-cell response by INF-gamma ELISPOT assay. Serum samples were tested for IgM and IgG anti-hepatitis E virus by ELISA. IgM antibodies to HAV were detected in 19 patients (8.1%), 37 (15.7%) with HBV, 10 (4.3%) with HCV. HEV infection was identified in 42 (16%) patients with AVH. Of the 200 contacts, 14 (7%) had serological evidence of recent HEV asymptomatic infection, showed stronger CMI responses than HEV infected subjects (2540 +/- 28 and 182 +/- 389 ISCs/106 cells, respectively; P < 0.05). In conclusion, HEV is a major cause of AVH in Egypt. Asymptomatic HEV patients are likely to have stronger immune responses including CMI responses, than symptomatic cases.

Accession: 055579118

Download citation: RISBibTeXText

PMID: 22053611


Related references

Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17. Bmc Infectious Diseases 19(1): 159, 2019

Hepatitis B and hepatitis A markers in 33 cases of acute hepatitis B surface antigen-negative, hepatitis A virus antibody-positive viral hepatitis. Importance of immune complexes. Minerva Medica 73(18): 1169-1172, 1982

Humoral immune response in Japanese acute hepatitis patients with hepatitis C virus infection. Canadian Journal of Gastroenterology 14(7): 593-598, 2000

Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance. Plos Pathogens 14(9): E1007290, 2018

Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis. Anticancer Research 19(5c): 4565-4569, 2000

Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability. Journal of Hepatology 50(4): 693-704, 2009

Incidence of hepatitis B virus (HBV) infection amongst clinically diagnosed acute viral hepatitis cases and relative risk of development of HBV infection in high risk groups in Calcutta. Indian Journal of Public Health 42(2): 56-58, 1999

Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt. Eastern Mediterranean Health Journal 16(4): 356-361, 2010

Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Archives of Internal Medicine 153(14): 1705-1712, 1993

Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. Journal of Clinical Virology 58(2): 374-377, 2014

The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection. Zeitschrift für Gastroenterologie 47(6): 531-540, 2009

Risk factors of chronic hepatitis in antiretroviral-treated HIV infection, without hepatitis B or C viral infection. Aids Research and Therapy 10: 21, 2013

Associated risk factors for hepatitis C prevalence and response to hepatitis B vaccine in acute leukemia patients at the National Childrens Hospital in San Jose, Costa Rica. Journal of Investigative Medicine 49(1): 61A, 2001

Case control study to identify risk factors for acute hepatitis C virus infection in Egypt. Bmc Infectious Diseases 12: 294, 2013

Case-control study to evaluate risk factors for acute hepatitis B virus infection in Egypt. Eastern Mediterranean Health Journal 16(1): 4-9, 2010